Spectrum of Henoch-Schonlein Purpura in Children: A Single-Center Experience from Western Provence of Saudi Arabia

Abstract Full-Text HTML XML Download Download as PDF (Size:789KB) PP. 17-22
DOI: 10.4236/ojra.2015.51004    3,066 Downloads   3,927 Views   Citations

ABSTRACT

The aim of this study was to describe the common presentation, frequency, and complications of Henoch-Schonlein purpura (HSP) in patients <18 years who were followed up at King Abdulaziz University Hospital, Jeddah over the last 12 years. We performed a retrospective chart review of the medical records of all patients diagnosed as HSP. During this period, only 29 cases were reported (15 males, 14 females), with the mean age at the diagnosis 7.5 years. 82% percent of the patients had joint involvement in the form of arthritis or arthralgia; 17.2% had no joint involvement. Abdominal manifestations were reported in 72.4% of the patients, while renal involvement was documented in 24.1% of the cases; two patients had scrotal involvement. Four patients (13.7%) had a recurrence within four months of HSP diagnosis. However, all patients had full recovery within a month. More research is warranted to study the prevalence, clinical manifestations, preceding factors, and complications of HSP in a Saudi-based cohort.

Cite this paper

Bukhari, E. , Al-Sofyani, K. and Muzaffer, M. (2015) Spectrum of Henoch-Schonlein Purpura in Children: A Single-Center Experience from Western Provence of Saudi Arabia. Open Journal of Rheumatology and Autoimmune Diseases, 5, 17-22. doi: 10.4236/ojra.2015.51004.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Tullus, K. and Marks, S.D. (2009) Vasculitis in Children and Adolescents: Clinical Presentation, Etiopathogenesis, and Treatment. Paediatric Drugs, 11, 375-380.
http://dx.doi.org/10.2165/11316120-000000000-00000
[2] Saulsbury, F.T. (2010) Henoch-Schonlein Purpura. Current Opinion in Rheumatology, 22, 598-602.
http://dx.doi.org/10.1097/BOR.0b013e32833af608
[3] Trnka, P. (2013) Henoch-Schonlein Purpura in Children. Journal of Paediatrics and Child Health, 49, 995-1003.
http://dx.doi.org/10.1111/jpc.12403
[4] Ozen, S., Pistorio, A., Iusan, S.M., Bakkaloglu, A., Herlin, T., Brik, R., Ruperto, N., et al. (2010) EULAR/PRINTO/ PRES Criteria for Henoch-Schonlein Purpura, Childhood Polyarteritis Nodosa, Childhood Wegener Granulomatosis and Childhood Takayasu Arteritis: Ankara 2008. Part II: Final Classification Criteria. Annals of the Rheumatic Disease, 69, 798-806.
http://dx.doi.org/10.1136/ard.2009.116657
[5] Al Harbi, N.N. (1996) Henoch-Schoenlein Syndrome in Children: Experience from Southern Part of Saudi Arabia. East African Medical Journal, 73, 191-193.
[6] Al Rasheed, S.A., Abdurrahman, M.B., Al Mugeiren, M.M. and Al Fawaz, I.M. (1991) Henoch-Schonlein Syndrome in Saudi Arabia. Journal of Tropical Pediatrics, 37, 127-130.
http://dx.doi.org/10.1093/tropej/37.3.127
[7] Lardhi, A.A. (2012) Henoch-Schonlein Purpura in Children from the Eastern Province of Saudi Arabia. Saudi Medical Journal, 33, 973-978.
[8] Tabel, Y., Inanc, F.C., Dogan, D.G. and Elmas, A.T. (2012) Clinical Features of Children with Henoch-Schonlein Purpura: Risk Factors Associated with Renal Involvement. Iranian Journal of Kidney Disease, 6, 269-274.
[9] Peru, H., Soylemezoglu, O., Bakkaloglu, S.A., Elmas, S., Bozkaya, D., Elmaci, A.M., Kara, F., Buyan, N. and Hasanoglu, E. (2008) Henoch Schonlein Purpura in Childhood: Clinical Analysis of 254 Cases over a 3-Year Period. Clinical Rheumatology, 27, 1087-1092.
http://dx.doi.org/10.1007/s10067-008-0868-2
[10] Jennette, J.C. and Falk, R.J. (1997) Small-Vessel Vasculitis. New England Journal of Medicine, 337, 1512-1523.
http://dx.doi.org/10.1056/NEJM199711203372106
[11] Mir, S., Yavascan, O., Mutlubas, F., Yeniay, B. and Sonmez, F. (2007) Clinical Outcome in Children with Henoch-Schonlein Nephritis. Pediatric Nephrology, 22, 64-70.
http://dx.doi.org/10.1007/s00467-006-0278-0
[12] Choong, C.K. and Beasley, S.W. (1998) Intra-Abdominal Manifestations of Henoch-Schonlein Purpura. Journal of Paediatrics and Child Health, 34, 405-409.
http://dx.doi.org/10.1046/j.1440-1754.1998.00263.x
[13] Kawasaki, Y., Ono, A., Ohara, S., Suzuki, Y., Suyama, K., Suzuki, J. and Hosoya, M. (2013) Henoch-Schonlein Purpura Nephritis in Childhood: Pathogenesis, Prognostic Factors and Treatment. Fukushima Journal of Medical Science, 59, 15-26.
http://dx.doi.org/10.5387/fms.59.15
[14] Trapani, S., Micheli, A., Grisolia, F., Resti, M., Chiappini, E., Falcini, F. and De Martino, M. (2005) Henoch Schonlein Purpura in Childhood: Epidemiological and Clinical Analysis of 150 Cases over a 5-Year Period and Review of Literature. Seminars in Arthritis and Rheumatism, 35, 143-153.
http://dx.doi.org/10.1016/j.semarthrit.2005.08.007
[15] Weiss, P.F., Klink, A.J., Localio, R., Hall, M., Hexem, K., Burnham, J.M., Keren, R. and Feudtner, C. (2010) Corticosteroids May Improve Clinical Outcomes during Hospitalization for Henoch-Schonlein Purpura. Pediatrics, 126, 674-681.
http://dx.doi.org/10.1542/peds.2009-3348
[16] Foster, B.J., Bernard, C., Drummond, K.N. and Sharma, A.K. (2000) Effective Therapy for Severe Henoch-Schonlein Purpura Nephritis with Prednisone and Azathioprine: A Clinical and Histopathologic Study. Journal of Pediatrics, 136, 370-375.
http://dx.doi.org/10.1067/mpd.2000.103448

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.